Antineoplastic Agents
Carcinoma in Situ
Carcinoma, Transitional Cell
Clinical Trials as Topic
Combined Modality Therapy
Doxorubicin
Humans
Neoplasm Recurrence, Local
Urinary Bladder Neoplasms
